Bromadol HCL (systematic name 4-(4-bromophenyl)-4-(dimethylamino)-1-(2-phenylethyl)cyclohexanol; also known as BDPC ) is a potent narcotic analgesic with a distinctive arylcyclohexylamine chemical structure. It was developed by Daniel Lednicer at Upjohn in the 1970s. Initial studies estimated that it was around 10,000 times the strength of morphine in animal models. However, later studies assigned a value of 504 times the potency of morphine for the more active trans-isomer.
Bromadol HCL (BDPC) (efficient name 4-(4-bromophenyl)- 4-(dimethylamino)– 1-(2-phenylethyl)cyclohexanol; otherwise called bromadol) is a strong opiate pain relieving with an unmistakable arylcyclohexylamine substance structure. It was created by Daniel Lednicer at Upjohn in the 1970s. Initial studies assessed that it was around 10,000 times the quality of morphine in creature models. However, later studies doled out an estimation of 504 times the strength of morphine for the more dynamic trans-isomer.
Bromadol HCL BDPC has never been utilized as a part of people, however would be required to create impacts like those of other strong opioid agonists, including solid absense of pain, sedation, happiness, stoppage, tingling and respiratory sadness which could be unsafe or lethal. BDPC Formula :C22H29BrClNO Resistance and reliance would be required to grow quickly in light of the intensity
of the medication, as it is of a comparative quality to sufentanil thus would in all likelihood cause affirmed tachyphylaxis
taking after rehashed dosing, as is seen with the powerful fentanyl analogs.
Bromadol HCL BDPC (systematic name 4-(4-bromophenyl)-4-(dimethylamino)-1-(2-phenylethyl)cyclohexanol
Several related analogs such as the p-methyl and ring-unsubstituted compounds have also been investigated. BDPC is the lead compound in this series that attracted so much interest in it initially. narcotic analgesic A large number of analogs have been prepared, and the SAR is very well established. Lednicer constructed Dreiding models to show that the model of BDPC will give an exact overlay on a model of fentanyl.
Lednicer’s two parent compounds for BDPC. They are equipotent, arylcyclohexylamine chemical structure which is an unusual case for a simple cyclohexanone to display interchangeable equal potency with either a methyl or bromine in the same substitution, both having the same potency as pethidine. The p-Methyl was never tested as an analogue of BDPC because ‘We forgot’. acetylfentanyl Although Lednicer stated that he felt that the p-Me would be equipotent.